Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

The Advanced Therapies Congress

The Advanced Therapies Congress


Date of beginning

Monday, 07 September 2020


3 days




United Kingdom


Riette de Jager


This email address is being protected from spambots. You need JavaScript enabled to view it.


Advanced Therapies is Europe’s most important advanced therapies conference and exhibition. The event brings 300 expert speakers and 2,000 cell and gene professionals from biotech, pharma, payers, regulators, start-ups, investors, researchers and tech companies together. The agenda is organised around 12 tracks of exciting content, including: - cell therapy - immunotherapy - pricing and market access - manufacturing and bioprocess - clinical trials - rare diseases - cord blood - gene editing - regenerative medicing - pitch and partner - end to end logistics - gene therapy The event covers each stage of development of cell, gene and immunotherapy - from bioprocessing through clinical translation to reimbursement, market access and delivery to patient. For an updated speaker list, please visit: check the programme, please visit: book your ticket, please visit: Venue details: Business Design Centre, 52 Upper Street, N1 0QH, London, United Kingdom Prices:Standard Package 3 Days: GBP 2200.0Academic Package 3 Days: GBP 595.0Start Up Package 3 Days: GBP 1095.0Standard Package 2 Days: GBP 1695.0Academic Package 2 Days: GBP 425.0Start Up Package 2 Days: GBP 850.0 Speakers: Martin Pule; SVP; Founder and CSO and Clinical Senior Lecturer; Haematology; Autolus and UCL Cancer Institute; Prasad Adusumilli; Attending Surgeon; Memorial Sloan Kettering Cancer Center; Pascal Touchon; President; Chief Executive Officer and Board Member; Atara Biotherapeutics; Federico Mingozzi; CSO; Spark Therapeutics; Christina Coughlin; Chief Medical Officer; Tmunity Therapeutics; Steve Kanner; CSO; Caribou Biosciences; Bradley Campbell; President and Chief Operating Officer; Amicus Therapeutics; Adrian Woolfson; Head of RandD; Sangamo Therapeutics; Fred Chereau; President and CEO; LogicBio Therapeutics; Christopher R. Heery; CMO; Precision BioSciences; Joanne Kurtzberg; Professor of Pediatrics and Pathology; Director; Marcus Center for Cellular Cures; Duke University Medical Center Time: 9:00 am - 5:00 pm